33 Fourth dose bivalent mRNA vaccines containing BA.1 significantly augment neutralising antibody titres against SARS-COV-2 Omicron sub-lineages XBB and BQ.1.1 in healthy adults

Saved in:
Bibliographic Details
Published in:Clinical infection in practice 2023-12, Vol.20, p.100260, Article 100260
Main Authors: Wu, Mary, Carr, Edward, Harvey, Ruth, Gahir, Joshua, Townsley, Hermaleigh, Dowgier, Guilia, Hobbs, Agnieska, Herman, Lou, Ragno, Martina, Miah, Murad, Bawumia, Philip, Smith, Callie, Miranda, Mauro, Mears, Harriet, Adams, Lorin, Haptioglu, Emine, O'Reilly, Nicola, Warchal, Scott, Sawyer, Chelsea, Ambrose, Karen, Kelly, Gavin, Beale, Rupert, Papineni, Padmasayee, Corrah, Tumena, Gilson, Richard, Gamblin, Steve, Kassiotis, George, Libri, Vincenzo, Williams, Bryan, Swanton, Charles, Gandhi, Sonia, Bauer, David, Wall, Emma
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2590-1702
2590-1702
DOI:10.1016/j.clinpr.2023.100260